Results 171 to 180 of about 93,237 (289)
In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles [PDF]
Joseph O. Muga +3 more
openalex +1 more source
Iduronate 2‐sulfatase (IDS; purple) is expressed as a precursor protein that goes through multiple steps of maturation, modification, and trafficking to become an active lysosomal enzyme that degrades glycosaminoglycans. Our study shows that the transmembrane ubiquitin ligases RNF13 (orange) and RNF167 (pink) heterodimerize, affecting IDS intracellular
Valérie C. Cabana +4 more
wiley +1 more source
A review on molecular markers of <i>Plasmodium falciparum</i>. [PDF]
Abebe W, Woldesenbet D.
europepmc +1 more source
Therapeutic advances in pruritus as a model of personalized medicine
Recent advances in itch biology reveal that chronic pruritus arises from distinct neuroimmune pathways driven by cytokines, JAK, BTK and GPCRs. Targeted biologics and small molecule inhibitors such as dupilumab, nemolizumab, remibrutinib and JAK inhibitors precisely modulate these pathways, leading to a new era of personalized therapeutics in pruritus.
Kelsey Auyeung +2 more
wiley +1 more source
Issues associated with malaria self-medication in sub-Saharan Africa: A systematic literature review and meta-analysis. [PDF]
Amaka JI +9 more
europepmc +1 more source
Selection of a Strain of Plasmodium berghei highly resistant to Chloroquine (‘Resochin’) [PDF]
Sundaram Ramakrishnan +2 more
openalex +1 more source
Abstract Infection is a known cause of abdominal aortic aneurysm (AAA), and matrix metalloproteases‐2 (MMP‐2) secreted by vascular smooth muscle cells (SMCs) plays a key role in the structural disruption of the middle layer of the arteries during AAA progression.
Yi‐Wen Lin +6 more
wiley +1 more source
In this study, we repurposed human Aurora kinase‐specific inhibitors to identify potential antimalarial agents. Two inhibitors, hesperadin and TAE684, exhibited sub‐micromolar activity across multiple parasite stages, with hesperadin demonstrating significant potency and selectivity by specifically targeting PfArk1.
Henrico Langeveld +23 more
wiley +2 more sources

